We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.50 | 1.63% | 218.50 | 217.50 | 219.00 | 225.00 | 216.50 | 218.00 | 275,918 | 16:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -4.66 | 210.55M |
TIDMOXB
RNS Number : 8627P
Oxford Biomedica PLC
05 September 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
Hot Features
Premium
1 Issuer Oxford BioMedica PLC
------ ------------------------ ------------------------------------
2 Reason for notification Notification relates to DTR
3.1.2R
------ ------------------------ ------------------------------------
3 Name of PDMR Martin Diggle
------ ------------------------ ------------------------------------
4 Connected person Notification relates to following
connected persons:
Vulpes Testudo Fund
------ ------------------------ ------------------------------------
5 Notification Notification in respect of
in respect of holdings of persons in 4 above
------ ------------------------ ------------------------------------
6 Description Oxford BioMedica PLC ordinary
of shares shares of 1p each
------ ------------------------ ------------------------------------
7 Name of registered Vulpes Life Sciences Fund
shareholders - 549,932,000 shares
and number of Vulpes Testudo Fund - 33,334,434
shares shares
------ ------------------------ ------------------------------------
8 Nature of transaction Disposal
------ ------------------------ ------------------------------------
9 Number of shares N/A
acquired
------ ------------------------ ------------------------------------
10 Percentage of N/A
issued class
acquired
------ ------------------------ ------------------------------------
11 Shares disposed Vulpes Testudo Fund - 2,377,600
------ ------------------------ ------------------------------------
12 Percentage of Vulpes Testudo Fund - 0.08%
issued class
disposed
------ ------------------------ ------------------------------------
13/14 Price per share Vulpes Testudo Fund
of transactions, Sold 2,377,600 shares @ GBP0.1009,
and date 31 Aug 2017
------ ------------------------ ------------------------------------
15 Total holding Vulpes Life Sciences Fund
following notification - 549,932,000 shares
and total percentage 17.7%
holding following Vulpes Testudo Fund - 30,956,834
notification shares
1.0%
------ ------------------------ ------------------------------------
16 Date issuer 05 Sept 2017
informed
------ ------------------------ ------------------------------------
23 Any additional None
information
------ ------------------------ ------------------------------------
24 Contact name S. Paynter, Chief Financial
and telephone Officer
number Oxford BioMedica
+44 (0)1865 783000
------ ------------------------ ------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBGGDCBSGBGRU
(END) Dow Jones Newswires
September 05, 2017 06:45 ET (10:45 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
